The global cardiac troponin market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of cardiovascular diseases and rising awareness about cardiac troponin testing among physicians.
Laboratory Testing: The laboratory testing segment accounted for the largest share in the global cardiac troponin market in 2018, followed by point-of-care (PoC) testing segment. This can be attributed to the high accuracy and reliability offered by laboratory tests as compared with PoC tests. Laboratory tests are also more expensive than PoC tests, which limits their adoption in developing countries where healthcare infrastructure is not well developed.
Acute Coronary Syndrome: Acute coronary syndrome accounted for the largest share in terms of application in 2018, followed by myocardial infarction and congestive heart failure applications segments respectively. This can be attributed to higher incidence rates of acute coronary syndrome as compared with myocardial infarction or congestive heart failure applications globally due to its sudden onset and short duration symptoms that make it difficult for patients to identify it on their own without medical intervention or diagnosis from a physician or healthcare professional.
Cardiac troponin is a protein that is found in the heart muscle. It can be used to diagnose heart attacks and other cardiac conditions. Cardiac troponin levels are elevated in patients with acute coronary syndrome, myocardial infarction, and congestive heart failure.
Industry Growth Insights published a new data on “Cardiac Troponin Market”. The research report is titled “Cardiac Troponin Market research by Types (Laboratory Testing, Point-of-care Testing), By Applications (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure, Others Applications), By Players/Companies Abbott Diagnostics, Roche, bioMrieux, BG Medicine, Ortho Clinical Diagnostics, Singulex, Alere, Siemens Healthcare Diagnostics, Beckman Coulter, LifeSign”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiac Troponin Market Research Report
By Type
Laboratory Testing, Point-of-care Testing
By Application
Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure, Others Applications
By Companies
Abbott Diagnostics, Roche, bioMrieux, BG Medicine, Ortho Clinical Diagnostics, Singulex, Alere, Siemens Healthcare Diagnostics, Beckman Coulter, LifeSign
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Cardiac Troponin Market Report Segments:
The global Cardiac Troponin market is segmented on the basis of:
Types
Laboratory Testing, Point-of-care Testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure, Others Applications
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Diagnostics
- Roche
- bioMrieux
- BG Medicine
- Ortho Clinical Diagnostics
- Singulex
- Alere
- Siemens Healthcare Diagnostics
- Beckman Coulter
- LifeSign
Highlights of The Cardiac Troponin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Laboratory Testing
- Point-of-care Testing
- By Application:
- Acute Coronary Syndrome
- Myocardial Infarction
- Congestive Heart Failure
- Others Applications
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiac Troponin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cardiac troponin is a protein that is found in the heart and can be used to diagnose cardiac problems. It can also be used to monitor cardiac health over time.
Some of the major companies in the cardiac troponin market are Abbott Diagnostics, Roche, bioMrieux, BG Medicine, Ortho Clinical Diagnostics, Singulex, Alere, Siemens Healthcare Diagnostics, Beckman Coulter, LifeSign.
The cardiac troponin market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cardiac Troponin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cardiac Troponin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cardiac Troponin Market - Supply Chain
4.5. Global Cardiac Troponin Market Forecast
4.5.1. Cardiac Troponin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cardiac Troponin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Cardiac Troponin Market Absolute $ Opportunity
5. Global Cardiac Troponin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Cardiac Troponin Market Size and Volume Forecast by Type
5.3.1. Laboratory Testing
5.3.2. Point-of-care Testing
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Cardiac Troponin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Cardiac Troponin Market Size and Volume Forecast by Application
6.3.1. Acute Coronary Syndrome
6.3.2. Myocardial Infarction
6.3.3. Congestive Heart Failure
6.3.4. Others Applications
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Cardiac Troponin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Cardiac Troponin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Cardiac Troponin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Cardiac Troponin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Cardiac Troponin Demand Share Forecast, 2019-2029
9. North America Cardiac Troponin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Cardiac Troponin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Cardiac Troponin Market Size and Volume Forecast by Application
9.4.1. Acute Coronary Syndrome
9.4.2. Myocardial Infarction
9.4.3. Congestive Heart Failure
9.4.4. Others Applications
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Cardiac Troponin Market Size and Volume Forecast by Type
9.7.1. Laboratory Testing
9.7.2. Point-of-care Testing
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Cardiac Troponin Demand Share Forecast, 2019-2029
10. Latin America Cardiac Troponin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Cardiac Troponin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Cardiac Troponin Market Size and Volume Forecast by Application
10.4.1. Acute Coronary Syndrome
10.4.2. Myocardial Infarction
10.4.3. Congestive Heart Failure
10.4.4. Others Applications
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Cardiac Troponin Market Size and Volume Forecast by Type
10.7.1. Laboratory Testing
10.7.2. Point-of-care Testing
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Cardiac Troponin Demand Share Forecast, 2019-2029
11. Europe Cardiac Troponin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Cardiac Troponin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Cardiac Troponin Market Size and Volume Forecast by Application
11.4.1. Acute Coronary Syndrome
11.4.2. Myocardial Infarction
11.4.3. Congestive Heart Failure
11.4.4. Others Applications
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Cardiac Troponin Market Size and Volume Forecast by Type
11.7.1. Laboratory Testing
11.7.2. Point-of-care Testing
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y rowth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Cardiac Troponin Demand Share, 2019-2029
12. Asia Pacific Cardiac Troponin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Cardiac Troponin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Cardiac Troponin Market Size and Volume Forecast by Application
12.4.1. Acute Coronary Syndrome
12.4.2. Myocardial Infarction
12.4.3. Congestive Heart Failure
12.4.4. Others Applications
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Cardiac Troponin Market Size and Volume Forecast by Type
12.7.1. Laboratory Testing
12.7.2. Point-of-care Testing
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Cardiac Troponin Demand Share, 2019-2029
13. Middle East & Africa Cardiac Troponin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Cardiac Troponin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Cardiac Troponin Market Size and Volume Forecast by Application
13.4.1. Acute Coronary Syndrome
13.4.2. Myocardial Infarction
13.4.3. Congestive Heart Failure
13.4.4. Others Applications
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Cardiac Troponin Market Size and Volume Forecast by Type
13.7.1. Laboratory Testing
13.7.2. Point-of-care Testing
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Cardiac Troponin Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Cardiac Troponin Market: Market Share Analysis
14.2. Cardiac Troponin Distributors and Customers
14.3. Cardiac Troponin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Diagnostics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Roche
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. bioMrieux
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. BG Medicine
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Ortho Clinical Diagnostics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Singulex
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Alere
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Siemens Healthcare Diagnostics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Beckman Coulter
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. LifeSign
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
